In celebration of #WC2024, @_Anesthesiology is putting spotlight on #pain relief. Learn about vocacapsaicin for management of postsurgical pain. Don’t miss the infographic, visual abstract, podcast, and editorial. https://t.co/cbTjwFxAb1 #WC2024
Thank you Concentric Analgesics collaborators (presenter: Ben Vaughn, investigators: David Leiman & Harold Minkowitz) for presenting #vocacapsaicin data @IASPpain#WC2024. #IASP, #TRPV1
“This new [capsaicin] prodrug formulation may provide a novel approach to postoperative analgesia resulting from a single local injection that lasts for days.” Authors examine the challenges of current and future postoperative analgesic strategies: https://t.co/COHwDQib1J
"This is the first demonstration of a single intra-operative injection leading to earlier cessation of opioids after surgery. By targeting #TRPV1 receptors, #vocacapsaicin eclipses the duration of pain relief possible from local anesthetic formulations." https://t.co/U7ywvBkIk4
The fight to reduce harmful opioid prescribing is far from over. Policy efforts have had some success, but I’m excited to see promise in new innovations in the management of post surgical pain.
A new issue is out today! In the cover study, a single, local administration of vocacapsaicin during surgery reduced pain and opioid consumption for at least 96 hours after surgery compared to control. Read the article: https://t.co/KGRTEd1vg2